HomeCompareLSLCF vs EQR

LSLCF vs EQR: Dividend Comparison 2026

LSLCF yields 74074.07% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LSLCF wins by $2.415744206754136e+25M in total portfolio value
10 years
LSLCF
LSLCF
● Live price
74074.07%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.415744206754136e+25M
Annual income
$24,093,458,170,968,554,000,000,000,000,000.00
Full LSLCF calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — LSLCF vs EQR

📍 LSLCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLSLCFEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LSLCF + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LSLCF pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LSLCF
Annual income on $10K today (after 15% tax)
$6,296,296.30/yr
After 10yr DRIP, annual income (after tax)
$20,479,439,445,323,270,000,000,000,000,000.00/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, LSLCF beats the other by $20,479,439,445,323,270,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LSLCF + EQR for your $10,000?

LSLCF: 50%EQR: 50%
100% EQR50/50100% LSLCF
Portfolio after 10yr
$1.207872103377068e+25M
Annual income
$12,046,729,085,484,277,000,000,000,000,000.00/yr
Blended yield
99.74%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

LSLCF
No analyst data
Altman Z
2.1
Piotroski
1/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LSLCF buys
0
EQR buys
0
No recent congressional trades found for LSLCF or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLSLCFEQR
Forward yield74074.07%5.87%
Annual dividend / share$2.00$3.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$2.415744206754136e+25M$47.8K
Annual income after 10y$24,093,458,170,968,554,000,000,000,000,000.00$5,475.61
Total dividends collected$2.415324649887447e+25M$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: LSLCF vs EQR ($10,000, DRIP)

YearLSLCF PortfolioLSLCF Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$7,418,107$7,407,407.41$11,380$679.82+$7.41MLSLCF
2$5,143,352,679$5,135,415,304.54$13,014$837.25+$5143.34MLSLCF
3$3,333,209,626,932$3,327,706,239,565.15$14,961$1,036.20+$3333209.61MLSLCF
4$2,019,042,046,668,882$2,015,475,512,368,064.00$17,297$1,289.22+$2019042046.65MLSLCF
5$1,143,136,308,564,991,200$1,140,975,933,575,055,600.00$20,121$1,613.15+$1143136308564.97MLSLCF
6$604,956,777,533,732,400,000$603,733,621,683,567,900,000.00$23,561$2,030.84+$604956777533732.38MLSLCF
7$299,246,003,348,033,900,000,000$298,598,699,596,072,800,000,000.00$27,783$2,573.54+$299246003348033920.00MLSLCF
8$138,361,209,034,681,260,000,000,000$138,041,015,811,098,890,000,000,000.00$33,013$3,284.39+$138361209034681270272.00MLSLCF
9$59,798,034,180,193,710,000,000,000,000$59,649,987,686,526,590,000,000,000,000.00$39,547$4,223.51+$5.979803418019371e+22MLSLCF
10$24,157,442,067,541,360,000,000,000,000,000$24,093,458,170,968,554,000,000,000,000,000.00$47,791$5,475.61+$2.415744206754136e+25MLSLCF

LSLCF vs EQR: Complete Analysis 2026

LSLCFStock

Lachlan Star Limited, together with its subsidiaries, engages in the exploration of mineral properties in Australia. It explores for gold, silver, copper, nickel, cobalt, lead, zinc, and PGE deposits. The company holds 100% interests in the Princhester Magnesite project that includes two granted mining leases located to the northwest of Rockhampton, Queensland; and the Killaloe gold project consists of two contiguous exploration licenses and the separate Buldania mining license covering an area of approximately 94 square kilometers located in the Eastern Goldfields, Western Australia. It also holds 75% interest in the Koojan project located in the New Norcia region, Western Australia. The company was formerly known as Toodyay Resources Limited and changed its name to Lachlan Star Limited in November 2007. Lachlan Star Limited was incorporated in 1970 and is based in West Perth, Australia.

Full LSLCF Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this LSLCF vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LSLCF vs SCHDLSLCF vs JEPILSLCF vs OLSLCF vs KOLSLCF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.